Filing Details
- Accession Number:
- 0001209191-15-069086
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-02 16:17:42
- Reporting Period:
- 2015-08-31
- Filing Date:
- 2015-09-02
- Accepted Time:
- 2015-09-02 16:17:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1142596 | Nuvasive Inc | NUVA | Surgical & Medical Instruments & Apparatus (3841) | 330768598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1289409 | Patrick Miles | 7475 Lusk Blvd. San Diego CA 92121 | President And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-08-31 | 139 | $18.31 | 92,627 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-08-31 | 700 | $53.07 | 91,927 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-08-31 | 14,300 | $53.35 | 77,627 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-09-01 | 15,000 | $52.03 | 62,627 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2015-08-31 | 139 | $0.00 | 139 | $18.31 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-01-03 | No | 4 | M | Direct |
Footnotes
- Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards.
- Sales effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1.
- Weighted average sales price from sales transactions ranging from $53.10 to $54.10. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
- Weighted average sales price from sales transactions ranging from $51.66 to $52.25. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
- The option, representing a right to purchase a total of 10,939 shares, was granted on January 3, 2006 and is fully vested.
Billionaire Hedge Funds
